# US 2023/0058847 A1 · Enhancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0058847 A1
- Document ID: US20230058847A1
- Status: Published application
- Kind: A1
- Application number: 17/791,564
- Filed: 2021-01-07
- Published: 2023-02-23
- Earliest claimed: 2020-01-10
- Assignees: Kaneka Corporation; Riken
- Applicants: Kaneka Corporation; Riken
- Inventors: Noriko ISHIKAWA; Masakazu KASHIHARA; Toshihiko KOMARI; Takeshi NAKANO
- Web page: https://patentgrep.com/patent/US20230058847A1

## CPC

- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N 5/10: Cells modified by introduction of foreign genetic material
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N 15/80: for fungi
- C12N 15/81: for yeasts
- C12N 15/8261: {with agronomic (input) traits, e.g. crop yield}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

An object of the present invention is to provide enhancers useful in enhancing the transcription activity of promoters. (i) A polynucleotide comprising a sequence of at least 20 consecutive nucleotides in the region of nucleotides 201 to 300 in SEQ ID NO: 1; or (ii) a polynucleotide that consists of a nucleotide sequence having at least 90% sequence identify to that of the polynucleotide (i), and has an effect to enhance promoter transcription activity, is used as an enhancer.

## Claims

### Claim 1

An enhancer comprising the following polynucleotide (i) or (ii):
(i) a polynucleotide comprising a sequence of at least 20 consecutive nucleotides in the region of nucleotides 201 to 300 in SEQ ID NO: 1; or
(ii) a polynucleotide that consists of a nucleotide sequence having at least 90% sequence identify to that of the polynucleotide (i), and has an effect to enhance promoter transcription activity.

### Claim 2 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a sequence of at least 40 consecutive nucleotides in the region of nucleotides 201 to 300 in SEQ ID NO: 1.

### Claim 3 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a sequence of at least 60 consecutive nucleotides in the region of nucleotides 201 to 300 in SEQ ID NO: 1.

### Claim 4 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a sequence of at least 80 consecutive nucleotides in the region of nucleotides 201 to 300 in SEQ ID NO: 1.

### Claim 5 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a nucleotide sequence represented by the region of nucleotides 261 to 280 in SEQ ID NO: 1, a nucleotide sequence represented by the region of nucleotides 271 to 290 in SEQ ID NO: 1, or a nucleotide sequence represented by the region of nucleotides 281 to 300 in SEQ ID NO: 1.

### Claim 6 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a nucleotide sequence represented by the region of nucleotides 201 to 240 in SEQ ID NO: 1, a nucleotide sequence represented by the region of nucleotides 221 to 260 in SEQ ID NO: 1, a nucleotide sequence represented by the region of nucleotides 241 to 280 in SEQ ID NO: 1, or a nucleotide sequence represented by the region of nucleotides 261 to 300 in SEQ ID NO: 1.

### Claim 7 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a nucleotide sequence represented by the region of nucleotides 201 to 300 in SEQ ID NO: 1.

### Claim 8 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a nucleotide sequence represented by the region of nucleotides 1 to 300 in SEQ ID NO: 1.

### Claim 9 (depends on 1)

The enhancer according to claim 1, wherein the polynucleotide (i) comprises a nucleotide sequence represented by SEQ ID NO: 1.

### Claim 10 (depends on 1)

The enhancer according to claim 1, further comprising a nucleic acid fragment having a nucleotide sequence represented by CACGTG, wherein the nucleic acid fragment is operably linked to the polypeptide (i) or (ii).

### Claim 11 (depends on 10)

The enhancer according to claim 10, wherein the enhancer comprises one to ten of the nucleic acid fragments.

### Claim 12 (depends on 10)

The enhancer according to claim 10, wherein the nucleic acid fragment consists of from 6 to 14 nucleotides.

### Claim 13 (depends on 1)

A nucleic acid construct comprising the enhancer according to claim 1, and a promoter.

### Claim 14 (depends on 13)

The nucleic acid construct according to claim 13, wherein the enhancer is operably inserted into, or operably linked to, the promoter.

### Claim 15 (depends on 1)

A vector comprising the enhancer according to claim 1.

### Claim 16 (depends on 13)

A vector comprising the nucleic acid construct according to claim 13.

### Claim 17 (depends on 1)

A host cell comprising the enhancer according to claim 1.

### Claim 18 (depends on 1)

A plant transfected with the enhancer according to claim 1.

### Claim 19 (depends on 1)

A method for enhancing the transcription activity of a promoter, the method comprising a step of operably inserting the enhancer according to claim 1 into the promoter, or operably linking said enhancer to the promoter.

### Claim 20 (depends on 1)

A method for increasing gene expression, the method comprising the steps of:
operably inserting the enhancer according to claim 1 into the promoter, or operably linking said enhancer to the promoter; and
causing expression of a gene located downstream of the promoter.

### Claim 21 (depends on 1)

A method for creating a highly productive plant, the method comprising the steps of:
incorporating a nucleic acid molecule in a plant cell, wherein the nucleic acid molecule comprises the enhancer according to claim 1, and a promoter into which said enhancer is operably inserted or to which said enhancer is operably linked, and has a gene located downstream of the promoter; and
creating a plant from the plant cell incorporating the nucleic acid molecule.
